Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics

• Status: Not yet recruiting
• Trial end date: 2022-06-02
• Target enrollment: 0
• Participant gender: All

Summary

the investigators hypothesized that Nalbuphine may be alternative pharmacological agent for prevention of emergence agitation in pediatrics who will be scheduled for elective lower abdominal surgical procedures (inguinal hernia repair and hypospadias) during sevoflurane anesthesia

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alexandria University
• Treatments: Dexmedetomidine; Nalbuphine

Criteria

Inclusion Criteria:

• ASA physical status I &II

• scheduled for elective lower abdominal surgical procedures (inguinal hernia repair and hypospadias) under general anesthesia

Exclusion Criteria:

• history of hypersensitivity to the studied drug,

• refusal of the legal guardian

• chronic or acute intake of any sedative or analgesic drugs,

• Psychological& emotional disorder.

• Cognitive or developmental disorders.

• severely agitated child at induction of anesthesia

• Any neurological condition that would limit the patient's ability to communicate with or understand nursing personnel,

• Existing contraindications to caudal block such as coagulopathy, local and systemic infection.

• Failure of the caudal block.